Andrew Radin

Biotech Entrepreneur

[Jorge Conde @JorgeCondeBio]

Biotech needs a tech upgrade.

We have astounding advances in science. Software needs to step up.

As founders build better software for science, SaaS will modernize how drugs are discovered, developed + distributed. @jayrughani & I sketch it out: ✍️@a16z
https://t.co/PbFRVKGHBa

[Tim Machado @machado_ta]

New lab, new lab website!

https://t.co/ziT6f1Xaxm

[Andrew Radin @AndrewRadin]

Check out my latest article: A Method for Innovation-Driven Entrepreneurs to Qualify Investors https://t.co/dsRyCIDLrj via @LinkedIn

[Stanford Medicine @StanfordMed]

New national survey app, called Apollo, helps users determine if they're likely to qualify for COVID-19 testing according to @CDCgov guidelines and identifies nearby testing facilities from a nationwide directory. https://t.co/9hOc4gj988

[Siddarth Satish @gauss_ceo]

I am very pleased to share that today @GaussSurgical has released the Apollo #COVID19 app to improve access to testing, enable contactless frontline screening, digitize the testing process, and facilitate @StanfordMed #coronavirus research. Thank you to our team, and to @Evive!

[Marianna Spring @mariannaspring]

Listen to this week’s @BBCtrending @bbcworldservice for more top tips on stopping coronavirus misinformation - plus the latest examples we’ve investigated 🧐 Presented by the brilliant @mwendling, reported by me with @FloraCarmichael + @BBCMonitoring https://t.co/GQcXINZnCX

[Andrew Radin @AndrewRadin]

@AllisonRBond Yes. Please DM me.

[Ruth Ann Crystal, MD @CatchTheBaby]

Please Retweet and share widely!

🔎 We've spent hours and hours aggregating valuable links to help doctors fight #COVID19. Here is the document: https://t.co/fqXrRwFueT

Please add your insights!

#MedTwitter #hcldr #FOAMed #COVID2019 #covid19UK

🚑 🌡️ 🔎 💊🚑 🌡️ 🔎 💊🚑

[BBC Future @BBC_Future]

It can be hard not to feel overwhelmed by the state of the world at the moment. But, even in times of stress and anxiety, you can take proactive steps to lift your mood. https://t.co/BmucSmUxwv

[Andrew Radin @AndrewRadin]

My @UCSanDiego roommate’s company acquired for a billion dollars? Not bad. 🤷‍♀️

[Tim Machado @machado_ta]

Excited to share news about @CTRLlabsCo and @facebook: Facebook's resources + CTRL-labs technology will drive forward the promise of neurotechnology!
https://t.co/cpHL74Ecmr

[Andrew Radin @AndrewRadin]

Welcome to the team Allen!

[Aria Pharmaceuticals @ariapharma]

We are pleased to announce the appointment of Allen Poirson, Ph.D. as Senior Vice President of Biopharmaceutical Business Development

https://t.co/O3Dd2rPggV

[Andrew Radin @AndrewRadin]

In 2014 @andrew_radin and I founded @twoXAR. Today I am transitioning to an advisory role. As our team, portfolio, and partnerships continue to grow, the company is well-positioned for ongoing success and I am excited for the next chapter of twoXAR. https://t.co/KQQCf3w4Lf

[Andrew Radin @AndrewRadin]

@GabeOtte Thanks for sharing your story Gabe. I always appreciate a touch of realism here in Silicon Valley. Creating a new sustainable system (company) in a larger unsustainable system (society) is very challenging. #theicebergillusionisreal

[Andrew Radin @AndrewRadin]

New Impact Report on artificial intelligence in drug development from @TuftsCSDD.

[Tufts Center for the Study of Drug Development @TuftsCSDD]

AVAILABLE NOW: @TuftsCSDD May/June 2019 Impact Report presents the results of a Tufts CSDD global survey of #pharma companies, CROs, tech & data providers, & other orgs. to assess the rate of & barriers to adoption of #AI in #drugdevelopment.
Learn more: https://t.co/7YbRHKAAtX

[BioWorld @BioWorld]

SK Biopharm, Twoxar combine AI technologies in discovery bid for lung cancer candidates https://t.co/A0JyVGMN5p

[Andrew Radin @andrew_radin]

Deal #3 of 2019 signed with SK Biopharmaceuticals. More details on the blog post https://t.co/eR6HbMicFJ

[BioWorld @BioWorld]

Ono inks deal with Twoxar as AI-backed drug discovery trend catches fire in Asia https://t.co/Ucb0mkgb0Z

[Vijay Pande @vijaypande]

Congrats on the new collaboration between ⁦@twoXAR⁩ & Ono Pharmaceutical: Discovering First-in-Class Drug Candidates for Neurological Diseases. AI coming to play an important role in some of the most therapeutically challenging & painful diseases. https://t.co/ubEMsfvRT2

[James Field @jejfield]

Excited to announce that @labgeni_us has teamed up with @tillotts_pharma to fight IBD. This important drug discovery program will be led by Dr Maria Bagniewska (Governance Lead), Dr Fiona Rowan (Asset Team Lead) and Dr Katya Putintseva (Data Science Lead). https://t.co/vdswIKzPDf

[Andrew Radin @AndrewRadin]

It’s been an interesting few months with trips to Asia to lock in shared risk / shared reward collaborations like today’s announcement with Ono Pharmaceutical and January’s announcement with 1ST Biotherapeutics.

[Aria Pharmaceuticals @ariapharma]

Today we announced our fourth industry partnership; and it's with another forward-thinking, Japan-headquartered pharmaceutical company, Ono Pharmaceutical. Learn more about the collaboration in @andrew_radin's blog post.

https://t.co/y5rAzYhfPC